Duan Q, Pang S, Wu W, Jiang B, Zhang W, Liu S
Vet Res. 2020; 51(1):93.
PMID: 32703260
PMC: 7376317.
DOI: 10.1186/s13567-020-00818-5.
Duan Q, Wu W, Pang S, Pan Z, Zhang W, Zhu G
Appl Environ Microbiol. 2020; 86(24).
PMID: 32169934
PMC: 7688215.
DOI: 10.1128/AEM.00217-20.
Levine M, Barry E, Chen W
Hum Vaccin Immunother. 2019; 15(6):1357-1378.
PMID: 30724648
PMC: 6663128.
DOI: 10.1080/21645515.2019.1578922.
Dubreuil J, Isaacson R, Schifferli D
EcoSal Plus. 2016; 7(1).
PMID: 27735786
PMC: 5123703.
DOI: 10.1128/ecosalplus.ESP-0006-2016.
Ikwap K, Larsson J, Jacobson M, Owiny D, Nasinyama G, Nabukenya I
BMC Microbiol. 2016; 16(1):178.
PMID: 27496201
PMC: 4974785.
DOI: 10.1186/s12866-016-0796-2.
Generation of Salmonella ghost cells expressing fimbrial antigens of enterotoxigenic Escherichia coli and evaluation of their antigenicity in a murine model.
Kim C, Hur J, Eo S, Park S, Lee J
Can J Vet Res. 2016; 80(1):40-8.
PMID: 26733731
PMC: 4686033.
Construction, characterization, and immunogenicity of an attenuated Salmonella enterica serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter.
Chen H, Schifferli D
Infect Immun. 2003; 71(8):4664-73.
PMID: 12874347
PMC: 165986.
DOI: 10.1128/IAI.71.8.4664-4673.2003.
Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H, Schifferli D
Infect Immun. 2000; 68(6):3129-39.
PMID: 10816454
PMC: 97544.
DOI: 10.1128/IAI.68.6.3129-3139.2000.
A conserved residue in the tip proteins of CS1 and CFA/I pili of enterotoxigenic Escherichia coli that is essential for adherence.
Sakellaris H, Munson G, Scott J
Proc Natl Acad Sci U S A. 1999; 96(22):12828-32.
PMID: 10536007
PMC: 23117.
DOI: 10.1073/pnas.96.22.12828.
Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria.
Rani D, Bayer M, Schifferli D
Clin Diagn Lab Immunol. 1999; 6(1):30-40.
PMID: 9874660
PMC: 95656.
DOI: 10.1128/CDLI.6.1.30-40.1999.
Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals.
Moon H, Bunn T
Vaccine. 1993; 11(2):213-200.
PMID: 8094931
PMC: 7130883.
DOI: 10.1016/0264-410x(93)90020-x.
Ordered translocation of 987P fimbrial subunits through the outer membrane of Escherichia coli.
Cao J, Khan A, Bayer M, Schifferli D
J Bacteriol. 1995; 177(13):3704-13.
PMID: 7601834
PMC: 177086.
DOI: 10.1128/jb.177.13.3704-3713.1995.
Effect of parenteral vaccination of dams on intestinal Escherichia coli in piglets with diarrhea.
Soderlind O, Olsson E, SMYTH C, Mollby R
Infect Immun. 1982; 36(3):900-6.
PMID: 7047401
PMC: 551414.
DOI: 10.1128/iai.36.3.900-906.1982.
Protection against colibacillosis in neonatal piglets by immunization of dams with procholeragenoid.
Furer E, Cryz Jr S, Dorner F, Nicolet J, Wanner M, Germanier R
Infect Immun. 1982; 35(3):887-94.
PMID: 7040250
PMC: 351130.
DOI: 10.1128/iai.35.3.887-894.1982.
Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli.
KLIPSTEIN F, Engert R, Clements J
Infect Immun. 1981; 32(3):1100-4.
PMID: 7019087
PMC: 351564.
DOI: 10.1128/iai.32.3.1100-1104.1981.
Protective effect of immunization with heat-labile enterotoxin in gnotobiotic rats monocontaminated with enterotoxigenic Escherichia coli.
KLIPSTEIN F, Engert R, SHORT H
Infect Immun. 1980; 28(1):163-70.
PMID: 6991436
PMC: 550907.
DOI: 10.1128/iai.28.1.163-170.1980.
Vaccination of cows with a K99 extract to protect newborn calves against experimental enterotoxic colibacillosis.
Nagy B
Infect Immun. 1980; 27(1):21-4.
PMID: 6987168
PMC: 550715.
DOI: 10.1128/iai.27.1.21-24.1980.
Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin.
KLIPSTEIN F, Engert R, Clements J
Infect Immun. 1982; 37(2):550-7.
PMID: 6749682
PMC: 347569.
DOI: 10.1128/iai.37.2.550-557.1982.
Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans.
Levine M, Ristaino P, Marley G, Smyth C, Knutton S, Boedeker E
Infect Immun. 1984; 44(2):409-20.
PMID: 6370866
PMC: 263534.
DOI: 10.1128/iai.44.2.409-420.1984.
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.
Levine M, Kaper J, Black R, Clements M
Microbiol Rev. 1983; 47(4):510-50.
PMID: 6363898
PMC: 281589.
DOI: 10.1128/mr.47.4.510-550.1983.